Risankizumab Side Effects
Medically reviewed by Drugs.com. Last updated on April 4, 2020.
For the Consumer
Applies to risankizumab: subcutaneous solution
Side effects requiring immediate medical attention
Along with its needed effects, risankizumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking risankizumab:
- Body aches or pain
- chest pain
- difficulty in breathing
- ear congestion
- fast heartbeat
- increase in bone pain
- itching, pain, redness, swelling, tenderness, or warmth on the skin
- loss of voice
- painful blisters on the trunk of the body
- rapid, shallow breathing
- runny or stuffy nose
- sore throat
- tightness in the chest
- unusual tiredness or weakness
- Itching of the genitals or other skin areas
- scaling of the skin
- Burning, itching, and pain in hairy areas, pus at the root of the hair
- hives or welts, itching, skin rash
Side effects not requiring immediate medical attention
Some side effects of risankizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
For Healthcare Professionals
Applies to risankizumab: subcutaneous kit
Very common (10% or more): Upper respiratory infections (e.g., respiratory tract infection [viral, bacterial, unspecified], sinusitis [including acute], rhinitis, nasopharyngitis, pharyngitis [including viral], tonsillitis) (13%)[Ref]
Common (1% to 10%): Fatigue, asthenia[Ref]
1. "Product Information. Skyrizi (risankizumab)." AbbVie US LLC, North Chicago, IL.
Frequently asked questions
- What are the new drugs for the treatment of plaque psoriasis?
- Skyrizi vs Ilumya. What’s the difference?
More about risankizumab
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- 2 Reviews
- Drug class: interleukin inhibitors
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.